spacer
spacer

PDBsum entry 4xui

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase/hydrolase inhibitor PDB id
4xui

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
215 a.a.
Ligands
2VC ×3
EDO ×4
Waters ×81
PDB id:
4xui
Name: Hydrolase/hydrolase inhibitor
Title: Crystal structure analysis of cruzain bound to the no-covalent analog of wrr-483 (wrr-669)
Structure: Cruzipain. Chain: a, b, c. Fragment: unp residues 122-337. Synonym: cruzaine,major cysteine proteinase. Engineered: yes
Source: Trypanosoma cruzi. Organism_taxid: 5693. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
2.51Å     R-factor:   0.163     R-free:   0.189
Authors: A.Tochowicz,J.H.Mckerrow
Key ref: B.D.Jones et al. (2016). Synthesis and Evaluation of Oxyguanidine Analogues of the Cysteine Protease Inhibitor WRR-483 against Cruzain. Acs Med Chem Lett, 7, 77-82. PubMed id: 26819670 DOI: 10.1021/acsmedchemlett.5b00336
Date:
26-Jan-15     Release date:   11-Mar-15    
Supersedes: 4pi4
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P25779  (CYSP_TRYCR) -  Cruzipain from Trypanosoma cruzi
Seq:
Struc:
467 a.a.
215 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.3.4.22.51  - cruzipain.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1021/acsmedchemlett.5b00336 Acs Med Chem Lett 7:77-82 (2016)
PubMed id: 26819670  
 
 
Synthesis and Evaluation of Oxyguanidine Analogues of the Cysteine Protease Inhibitor WRR-483 against Cruzain.
B.D.Jones, A.Tochowicz, Y.Tang, M.D.Cameron, L.I.McCall, K.Hirata, J.L.Siqueira-Neto, S.L.Reed, J.H.McKerrow, W.R.Roush.
 
  ABSTRACT  
 
A series of oxyguanidine analogues of the cysteine protease inhibitor WRR-483 were synthesized and evaluated against cruzain, the major cysteine protease of the protozoan parasite Trypanosoma cruzi. Kinetic analyses of these analogues indicated that they have comparable potency to previously prepared vinyl sulfone cruzain inhibitors. Co-crystal structures of the oxyguanidine analogues WRR-666 (4) and WRR-669 (7) bound to cruzain demonstrated different binding interactions with the cysteine protease, depending on the aryl moiety of the P1' inhibitor subunit. Specifically, these data demonstrate that WRR-669 is bound noncovalently in the crystal structure. This represents a rare example of noncovalent inhibition of a cysteine protease by a vinyl sulfone inhibitor.
 

 

spacer

spacer